Evidence map›Paper›PMID 33028345›Full record

ArticleHealth and quality of life outcomes2020

EQ-5D-5L Slovenian population norms.

Valentina Prevolnik Rupel, Marko Ogorevc

Abstract read
In one paragraph

Article in Health and quality of life outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Population norms for the EQ-5D-5L for Hungary: comparison of online surveys and computer assisted personal interviews.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  4. How to Assess Health Gains.Healthcare (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Health-related quality of life assessed by EQ-5D-5L and its determinants among rural adults: result from the Henan rural cohort study.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  10. Canada population norms for the EQ-5D-5L.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  11. Article
  12. Hungarian population norms for the 15D generic preference-accompanied health status measure.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  13. Article
  14. Article
  15. EQ-5D-5L Portuguese population norms.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  16. Article
  17. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.Health and quality of life outcomes · 2023
    Article
  18. EQ-5D-5L Population Norms for Italy.Applied health economics and health policy · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Valentina Prevolnik RupelInstitute for Economic Research, Kardeljeva ploščad 17, 1000, Ljubljana, Slovenia. katka.rupel@gmail.com.ORCID http://orcid.org/0000-0002-1238-7156
Marko OgorevcInstitute for Economic Research, Kardeljeva ploščad 17, 1000, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0001-9970-3045

Funding

H2020 European Research Council 779312Javna Agencija za Raziskovalno Dejavnost RS P5-0096
6 · The paper itself

Abstract

backgroundThe study aims to present Slovenian EQ-5D-5L population norms for different age and gender subgroups that can be used as reference values in future studies concerning health status. The secondary aim is to compare those norms with population norms from some other countries in Europe and elsewhere.

methodsThe cross-sectional survey was conducted between November 2019 and February 2020 via online panel. 1071 adults aged 18+ were included in the survey. The general population was sampled using quota sampling in terms of age, gender, and NUTS2 region. In the study, the EQ-5D-5L Slovenian online version was used. Descriptive statistics was used to present health status by age groups and genders for the EQ-5D-5L descriptive system, EQ VAS and the EQ-5D-5L index score. The latter was derived from Slovenian EQ-3D-3L tariff, transformed to five levels using the crosswalk methodology.

resultsThe mean EQ VAS score in the Slovenian population was 79.9, mean utility index was 0.808. 28.2% of the population did not have problems on any dimension and 3.9% of the population had problems on all dimensions. Persons residing in Western Slovenia had, on average, 0.016 higher utility score, compared to Eastern Slovenia. Effect of gender was not significant. Age was negatively associated with both utility index and EQ VAS score. Education was positively correlated to health status. Problems on dimensions were generally increasing with age, except for anxiety/depression dimension, where youngest group (ages 18-29) reported more anxiety/depression compared to older counterparts. Self-reported anxiety/depression was more pronounced in women.

conclusionsSimilarly to other countries, the health generally deteriorates with age, except for the anxiety/depression dimension where the share of respondents reporting no problems was lowest in the youngest age group. The open question for the future remains, whether population norms from this online sample differ significantly from the actual EQ-5D-5L health status data of the Slovenian general population.

Indexed as

Health StatusQuality of LifeAdolescentAdultAgedAge FactorsCross-Sectional StudiesFemaleHumansMaleMiddle AgedReference ValuesSurveys and QuestionnairesYoung AdultEQ-5D-5LEQ VASHealth statusPatient-reported outcomesPopulation normsReference values

Identifiers

PMID33028345
PMCPMC7542912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.